CVE-2023-20273
KEV の『悪用』には未遂(脆弱でない環境やハニーポットでの試行)が含まれ、特定の組織が侵害されたことを意味しない。
KEV の登録内容
- vulnerabilityName
- Cisco IOS XE Web UI Command Injection Vulnerability
- vendorProject
- Cisco
- product
- Cisco IOS XE Web UI
- dateAdded
- 2023-10-23
- shortDescription
- Cisco IOS XE contains a command injection vulnerability in the web user interface. When chained with CVE-2023-20198, the attacker can leverage the new local user to elevate privilege to root and write the implant to the file system. Cisco identified CVE-2023-20273 as the vulnerability exploited to deploy the implant. CVE-2021-1435, previously associated with the exploitation events, is no longer believed to be related to this activity.
- requiredAction
- Verify that instances of Cisco IOS XE Web UI are in compliance with BOD 23-02 and apply mitigations per vendor instructions. For affected products (Cisco IOS XE Web UI exposed to the internet or to untrusted networks), follow vendor instructions to determine if a system may have been compromised and immediately report positive findings to CISA.
- dueDate
- 2023-10-27
- knownRansomwareCampaignUse
- Unknown
- forensicTriage
- No
- notes
- https://sec.cloudapps.cisco.com/security/center/content/CiscoSecurityAdvisory/cisco-sa-iosxe-webui-privesc-j22SaA4z; https://nvd.nist.gov/vuln/detail/CVE-2023-20273
- cwes
- CWE-78
観測した変更
取り込み開始以降、KEV の値の変更は観測していません。
CVE レコード(CVE Program)
CVE レコードはまだ取り込んでいません(CVE Program に未公開の場合は CVE 未公開)。
外部のページ
出典: CISA Known Exploited Vulnerabilities Catalog(CISA KEV。CC0 1.0)。 詳しくは出典表記とライセンス。
出典: CVE Program(CVE レコード)。詳しくは出典表記とライセンス。
Copyright © 1999-2026, The MITRE Corporation. CVE is a trademark and the CVE logo is a registered trademark of The MITRE Corporation. MITRE hereby grants you a perpetual, worldwide, non-exclusive, no-charge, royalty-free, irrevocable copyright license to reproduce, prepare derivative works of, publicly display, publicly perform, sublicense, and distribute Common Vulnerabilities and Exposures (CVE™). Any copy you make for such purposes is authorized provided that you reproduce MITRE's copyright designation and this license in any such copy.